Explore the role of liver stiffness measurement (LSM) in the noninvasive risk stratification of liver nodule development in patients with Fontan-associated liver disease (FALD).
This study provides important insights into early risk identification and surveillance strategies, supporting improved clinical decision-making in this complex patient population.



![The Asian Pacific Association for the Study of the Liver [APASL]](https://www.apasl.info/wp-apasl/wp-content/themes/apasl/images/header/img_apasl_logo.png)